Profile
Bart Welten served as Chief Financial Officer at Avantium NV from 2020 to 2023, at DSM Resins BV from 2006 to 2012, and at Centrient Pharmaceuticals Netherlands BV in 2018-2019.
He also held the position of Chief Financial Officer at DSM Anti Infectives BV.
Mr. Welten holds an MBA from Boston College and an undergraduate degree from the University of Leiden.
Former positions of Bart Welten
Companies | Position | End |
---|---|---|
AVANTIUM N.V. | Director of Finance/CFO | 2022-12-31 |
Centrient Pharmaceuticals Netherlands BV
Centrient Pharmaceuticals Netherlands BV BiotechnologyHealth Technology Centrient Pharmaceuticals Netherlands BV produces green beta-lactams antibiotics. It offers active pharmaceutical ingredients and drug products for anti-infectives such as antibiotics, anti-fungals and other therapeutic classes like cholesterol lowering medicines. The company was founded in 1869 and is headquartered in Delft, the Netherlands. | Director of Finance/CFO | 2019-01-31 |
DSM Resins BV | Director of Finance/CFO | 2012-06-30 |
DSM Anti Infectives BV
DSM Anti Infectives BV Pharmaceuticals: MajorHealth Technology Part of DSM-Firmenich AG, DSM Anti Infectives BV is a Dutch company that manufactures ingredients for antibiotics. The private company is based in Delft, the Netherlands. DSM Anti Infectives was acquired by Sinochem Group Co., Ltd. from DSM BV on August 31, 2011 for $277.08 million. | Director of Finance/CFO | - |
Training of Bart Welten
Boston College | Masters Business Admin |
University of Leiden | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
AVANTIUM N.V. | Producer Manufacturing |
Private companies | 3 |
---|---|
Centrient Pharmaceuticals Netherlands BV
Centrient Pharmaceuticals Netherlands BV BiotechnologyHealth Technology Centrient Pharmaceuticals Netherlands BV produces green beta-lactams antibiotics. It offers active pharmaceutical ingredients and drug products for anti-infectives such as antibiotics, anti-fungals and other therapeutic classes like cholesterol lowering medicines. The company was founded in 1869 and is headquartered in Delft, the Netherlands. | Health Technology |
DSM Resins BV | |
DSM Anti Infectives BV
DSM Anti Infectives BV Pharmaceuticals: MajorHealth Technology Part of DSM-Firmenich AG, DSM Anti Infectives BV is a Dutch company that manufactures ingredients for antibiotics. The private company is based in Delft, the Netherlands. DSM Anti Infectives was acquired by Sinochem Group Co., Ltd. from DSM BV on August 31, 2011 for $277.08 million. | Health Technology |
- Stock Market
- Insiders
- Bart Welten